Feasibility of mesothelial transplantation during experimental peritoneal dialysis and peritonitis

International Journal of Artificial Organs

Volumn 30, Issue 6, 2007, Pages 513-519

  Hekking, L H P ^a   van den Born, Jacob ^b,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Department of Nephrology   (Netherlands)

Author keywords

Mesothelium; Peritoneum; Therapy

Indexed keywords

CELLS; DIALYSIS;

CELL LAYERS; CELL TRANSPLANTATION; CONTINUOUS EXPOSURE; HOMOEOSTASIS; MESOTHELIAL CELLS; MESOTHELIUM; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS FLUIDS; PERITONEUM; THERAPY;

CYTOLOGY;

AUTOTRANSPLANTATION; CELL CULTURE; CELL TRANSPLANTATION; FIBROSIS; HOMEOSTASIS; HUMAN; MESOTHELIUM CELL; NONHUMAN; PERITONEAL DIALYSIS; PERITONEUM; PERITONEUM ADHESION; PERITONITIS; REVIEW; SCLEROSIS; TISSUE INJURY;

EID: 34547901422     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703000609     Document Type: Review

References (52)

1. Jorres A, Topley N, Witowski J, Liberek T, Gahl GM. Impact of peritoneal dialysis solutions on peritoneal immune defense. Perit Dial Int 1992; 13 (suppl 2): S291-4.
2. Topley N, Williams JD. Effect of peritoneal dialysis on cytokine production by peritoneal cells. Blood Purif 1996; 14: 188-97.
3. Henderson IS, Couper IA, Lumsden A. The effect of shelf life of peritoneal dialysis fluid on ultrafiltration in CAPD. In: La Greca, ed. Peritoneal dialysis. Milan, Italy: Wichtig Editore, 1986; 85-6.
4. Henderson IS, Couper IA, Lumsden A. Potentially irritant glucose metabolites in unused CAPD fluid. In: Winchester JW, ed. Frontiers in peritoneal dialysis. New York: Field, Rich, 1985; 261-4.
5. Schalkwijk CG, Posthuma N, ten Brink HJ, ter Wee PM, Teerlink T. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids. Perit Dial Int 1999; 19: 325-33.
6. Cendoroglo M, Sundaram S, Jaber JL, Pereira BJ. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood and polymorphonuclear cell functions in vitro. Am J Kidney Dis 1998; 31: 273-82.
7. Dobbie JW, Anderson JD, Hind C. Long-term effects of peritoneal dialysis on peritoneal morphology. Perit Dial Int 1994; 14: S16-20.
8. Williams JD, Graig KJ, Topley N, et al. Morphological changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-9.
9. Chailley-Heu B, Rubio S, Rougier JR et al. Expression of hydrophilic surfactant proteins by mesentery cells in rat and man. Biochem J 1997; 328: 251-6.
10. Dobbie JW, Pavlina T, Lloyd J, Johnson RC. Phosphatidylcholine synthesis by peritoneal mesothelium: Its implication for peritoneal dialysis. Am J Kidney Dis 1988; 12: 31-6.
11. Yung S, Coles GA, Williams JD, Davies M. The source and possible significance of hyaluronic acid in the peritoneal cavity. Kidney Int 1994; 46: 527-33.
12. Yung S, Thomas GJ, Stylianou E, Williams JD, Coles GA, Davies M. Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesise and secrete mainly small dermatan sulfate proteoglycans. Am J Pathol 1995; 146: 520-9.
13. Flessner MF. The transport barrier in intraperitoneal therapy. Am J Physiol Renal Physiol 2005; 288: F433-42.
14. Aroeira LS, Aguilera A, Selgas R, et al. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: Role of vascular endothelial growth factor. Am J Kidney Dis 2005; 46: 938-48.
15. Verger C, Luger A, Moore HL, Nolph KD. Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury. Kidney Int 1983; 23: 823-31.
16. Kaufman Ola, Rostovshchikov AS, Kranchev AK, Paukov VS. [Reaction of rat penitoneal mesothelial cells in aseptic and bacterial peritonitis]. Biull Eksp Biol Med 1982; 94: 100-4. Russian.
17. Beavis MJ, Williams JD, Hoppe J, Topley N. Human peritoneal fibroblast proliferation in 3-dimensional culture: Modulation by cytokines, growth factors and peritoneal dialysis effluent. Kidney Int 1997; 51: 205-15.
18. Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 1997; 99: 1313-21.
19. Honda K, Nitta K, Horita S, Yumura W, Nihei H. Morphological changes in the vasculature of patients on CAPD with ultrafiltration failure. Nephron 1996; 72: 171-6.
20. Mateijsen MA, Van der Wal AC, Hendriks PM, et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999; 19: 517-25.
21. Hekking LH, Zareie M, Driesprong BA, et al. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J Am Soc Nephrol 2001; 12: 2775-86.
22. Pannekeet MM, Zemel D, Koomen GC, Struijk DG, Krediet RT. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD. Perit Dial Int 1995; 15: 217-25.
23. Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, Krediet RT. Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int 1997; 51: 888-93.
24. Krediet RT. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int 2001; 21: 560-7.
25. Le Poole CY, Welten AG, Weijmer MC, Valentijn RM, van Ittersum FJ, ter Wee PM. Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious. Perit Dial Int 2005; 25: S64-8.
26. Finkelstein E, Jekel J, Troidle L, Gorban-Brennan N, Finkelstein FO, Bia FJ. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis 2002; 39: 1278-86.
27. Visser CE, Brouwer-Steenbergen JJ, Schadee-Eestermans IL, Meijer S, Krediet RT, Beelen RH. Ingestion of Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli by human peritoneal mesothelial cells. Infect Immun 1996; 64: 3425-8.
28. Lameire N, Van Biesen W, Van Landschoot M, et al. Experimental models in peritoneal dialysis: A European experience. Kidney Int 1998; 54: 2194-206.
29. van Hinsbergh VW, Kooistra T, Scheffer MA, van Bockel JH, van Muijen GN. Characterisation and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990; 75: 1490-7.
30. Gries E, Kopp J, Thomae U, Kuhlmann H. Relation of intraperitoneal and intravascular coagulation and fibrinolysis related antigens in peritoneal dialysis. Thromb Haemost 1990; 63: 356-60.
31. Sitter T, Spannagl M, Schiffl H, Held E, van Hinsbergh VW, Kooistra T. Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: The role of mesothelial cells. Nephrol Dial Transplant 1995; 10: 677-83.
32. De Boer AW, Levi M, Reddingius RE, et al. Intraperitoneal hypercoagulation and hypofibrinolysis is present in childhood peritonitis. Pediatr Nephrol 1999; 13: 284-7.
33. Goedde M, Sitter T, Schiffl H, Brechtel U, Schramm W, Spannagl M. Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients. Perit Dial Int 1997; 17: 162-6.
34. Di Paolo N, Sacchi G, Vanni L, et al. Implant of autologous mesothelial cells in animals and a peritoneal dialysis patient. Int J Artif Organs 1989; 12: 485-501.
35. Di Paolo N, Vanni L, Sacchi G. Autologous implant of peritoneal mesothelium in rabbits and man. Clin Nephrol 1990; 34: 179-84.
36. Di Paolo N, Sacchi G, Vanni L, et al. Autologous peritoneal mesothelial cell implant in rabbits and peritoneal dialysis patients. Nephron 1991; 57: 323-31.
37. Hekking LH, Harvey VS, Havenith CE, et al. Mesothelial cell transplantation in models of acute inflammation and chronic peritoneal dialysis. Perit Dial Int 2003; 23: 323-30.
38. Hekking LH, Zweers MM, keuning ED, et al. Apparent successful mesothelial cell transplantation hampered by peritoneal activation, Kidney Int 2005; 68: 2362-7.
39. Nagy JA, Shockley TR, Masse EM, Harvey VS, Jackman RW. Mesothelial cell-mediated gene therapy: Feasibility of an ex vivo strategy. Gene Ther 1995; 2: 393-401.
40. Nagy JA, Shockley TR, Masse EM, Harvey VS, Hoff CM, Jackman RW. Systemic delivery of a recombinant protein by genetically modified mesothelial cells reseeded on the parietal peritoneal surface. Gene Ther 1995; 2: 402-10.
41. Jackman RW, Stapleton TD, Masse EM, et al. Enhancement of the functional repertoire of the rat parietal peritoneal mesothelium in vivo: directed expression of the anticoagulant and antiinflammatory molecule thrombomodulin. Hum Gene Ther 1998; 9: 1069-81.
42. Bertram P, Tietze L, Hoopmann M, Treutner KH, Mittermayer C, Schumpelick V. Intraperitoneal transplantation with isologous mesothelial cells for prevention of adhesions. Eur J Surg 1999; 165: 705-9.
43. Foley-Comer AJ, Herrick SE, Al-Mishlab T, Prele CM, Laurent GJ, Mutsaers SE. Evidence for incorporation of free-floating mesothelial cells as a mechanism for serosal healing. J Cell Sci 2002; 115: 1383-9.
44. Asano T, Takazawa R, Yamato M, et al. Transplantation of an autologous mesothelial cell sheet prepared from tunica vaginalis prevents post-operative adhesions in a canine model. Tissue Eng 2006; 12: 2629-37.
45. Hoff CM, Shockley TR. Peritoneal dialysis in the 21st century. The potential of gene therapy. J Am Soc Nephrol 2002; 13 (suppl): S117-24.
46. Lopéz-Cabrera M, Aguilera A, Aroeira LS, et al. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure. Perit Dial Int 2006; 26: 26-34.
47. Selgas R, Bajo A, Jimenez-Heffernan JA, et al. Epithelial-to-mesenchymal transition of the mesothelial cell its role in the response of the peritoneum to dialysis. Nephrol Dial Transplant 2006; 21: ii2-7.
48. Nevado J, Vallejo S, El-Assar M, Peiro C, Sanchez-Ferrer CF, Rodriquez-Manas L. Changes in the human peritoneal mesothelial cells during aging. Kidney Int 2006; 69: 313-22.
49. Henderson IS, Dobbie JW, Zaki MA, Wilson LS. Structure of the peritoneum and changes brought about by infection. Contrib Nephrol 1987; 57: 30-40.
50. Visser CE, Steenbergen J, Betjes MG, Koomen GC, Beelen RH, Krediet R. Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant 1995; 10: 64-9.
51. Visser CE, Brouwer-Steenbergen JJ, Postmus PE, et al. Renal function influences interleukin-8 background production by cultured human mesothelial cells. Adv Perit Dial 1996; 12: 15-8.
52. Herrick SE, Mutsaers SE. Mesothelial progenitor cells and their potential in tissue engineering. Int J Biochem Cell Biol 2004; 36: 621-42.